Figures & data
Table 1 Demographic and clinical characteristics of subjects
Table 2 Paired-samples test results
Figure 1 Bland–Altman plots of soluble protein markers in sputum supernatant. Bland–Altman plots of (A) IL1β; (B) IL5; (C) IL6; (D) IL8; (E) IL10; (F) IL13; (G) IL33; (H) sRAGE; (I) TNFα; and (J) VEGF.
![Figure 1 Bland–Altman plots of soluble protein markers in sputum supernatant. Bland–Altman plots of (A) IL1β; (B) IL5; (C) IL6; (D) IL8; (E) IL10; (F) IL13; (G) IL33; (H) sRAGE; (I) TNFα; and (J) VEGF.](/cms/asset/2b352b95-7f8a-44e9-af2e-5310e735ba25/dcop_a_187661_f0001_c.jpg)
Table 3 Intraclass correlation coefficient (ICC) assessment results
Figure 2 Bland–Altman plots of IgG autoantibodies in sputum supernatant. Bland–Altman plots of (A) anti-aggrecan IgG; (B) anti-amyloid IgG; (C) anti-CENP-B IgG; (D) anti-collagen I IgG; (E) anti-collagen II IgG; (F) anti-collagen IV IgG; (G) anti-cytochrome C IgG; (H) anti-cytokeratin 18 IgG; (I) anti-elastin IgG; (J) anti-HSP47 IgG; (K) anti-HSP70 IgG; (L) anti-SS-B IgG; and (M) anti-vimentin IgG.
![Figure 2 Bland–Altman plots of IgG autoantibodies in sputum supernatant. Bland–Altman plots of (A) anti-aggrecan IgG; (B) anti-amyloid IgG; (C) anti-CENP-B IgG; (D) anti-collagen I IgG; (E) anti-collagen II IgG; (F) anti-collagen IV IgG; (G) anti-cytochrome C IgG; (H) anti-cytokeratin 18 IgG; (I) anti-elastin IgG; (J) anti-HSP47 IgG; (K) anti-HSP70 IgG; (L) anti-SS-B IgG; and (M) anti-vimentin IgG.](/cms/asset/be509b30-4ea3-4f06-b07a-c5ec5fedfd1c/dcop_a_187661_f0002_c.jpg)
![Figure 2 Bland–Altman plots of IgG autoantibodies in sputum supernatant. Bland–Altman plots of (A) anti-aggrecan IgG; (B) anti-amyloid IgG; (C) anti-CENP-B IgG; (D) anti-collagen I IgG; (E) anti-collagen II IgG; (F) anti-collagen IV IgG; (G) anti-cytochrome C IgG; (H) anti-cytokeratin 18 IgG; (I) anti-elastin IgG; (J) anti-HSP47 IgG; (K) anti-HSP70 IgG; (L) anti-SS-B IgG; and (M) anti-vimentin IgG.](/cms/asset/6f7fceab-0947-4363-9328-d9d173283c1d/dcop_a_187661_f0002a_c.jpg)
Figure 3 Bland–Altman plots of IgM autoantibodies in sputum supernatant. Bland–Altman plots of (A) anti-aggrecan IgM; (B) anti-amyloid IgM; (C) anti-CENP-B IgM; (D) anti-collagen I IgM; (E) anti-collagen II IgM; (F) anti-collagen IV IgM; (G) anti-cytochrome C IgM; (H) anti-cytokeratin 18 IgM; (I) anti-elastin IgM; (J) anti-HSP47 IgM; (K) anti-HSP70 IgM; (L) anti-SS-B IgM; and (M) anti-vimentin IgM.
![Figure 3 Bland–Altman plots of IgM autoantibodies in sputum supernatant. Bland–Altman plots of (A) anti-aggrecan IgM; (B) anti-amyloid IgM; (C) anti-CENP-B IgM; (D) anti-collagen I IgM; (E) anti-collagen II IgM; (F) anti-collagen IV IgM; (G) anti-cytochrome C IgM; (H) anti-cytokeratin 18 IgM; (I) anti-elastin IgM; (J) anti-HSP47 IgM; (K) anti-HSP70 IgM; (L) anti-SS-B IgM; and (M) anti-vimentin IgM.](/cms/asset/c5ff06dc-ca90-4793-a0bb-dfdf2ef67118/dcop_a_187661_f0003_c.jpg)
![Figure 3 Bland–Altman plots of IgM autoantibodies in sputum supernatant. Bland–Altman plots of (A) anti-aggrecan IgM; (B) anti-amyloid IgM; (C) anti-CENP-B IgM; (D) anti-collagen I IgM; (E) anti-collagen II IgM; (F) anti-collagen IV IgM; (G) anti-cytochrome C IgM; (H) anti-cytokeratin 18 IgM; (I) anti-elastin IgM; (J) anti-HSP47 IgM; (K) anti-HSP70 IgM; (L) anti-SS-B IgM; and (M) anti-vimentin IgM.](/cms/asset/887741c2-11e3-42c6-93fc-9bfc85cc8697/dcop_a_187661_f0003a_c.jpg)
Figure 4 Bland–Altman plots of sputum cell counts. Bland–Altman plots of (A) sputum neutrophils; (B) sputum macrophages; (C) sputum eosinophils; and (D) sputum lymphocytes.
![Figure 4 Bland–Altman plots of sputum cell counts. Bland–Altman plots of (A) sputum neutrophils; (B) sputum macrophages; (C) sputum eosinophils; and (D) sputum lymphocytes.](/cms/asset/5adc7efd-240f-4bef-9bf3-400f124e9949/dcop_a_187661_f0004_c.jpg)
Figure S1 Scatter plots of soluble protein markers with pair-wise comparisons of the two measurements. Scatter plots of (A) IL1β; (B) IL5; (C) IL6; (D) IL8; (E) IL10; (F) IL13; (G) IL33; (H) sRAGE; (I) TNFα; and (J) VEGF.
Abbreviations: IL, interleukin; sRAGE, soluble receptor for advanced glycation end-products; TNFα, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.
![Figure S1 Scatter plots of soluble protein markers with pair-wise comparisons of the two measurements. Scatter plots of (A) IL1β; (B) IL5; (C) IL6; (D) IL8; (E) IL10; (F) IL13; (G) IL33; (H) sRAGE; (I) TNFα; and (J) VEGF.Abbreviations: IL, interleukin; sRAGE, soluble receptor for advanced glycation end-products; TNFα, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.](/cms/asset/2f939d99-61c1-42f4-8743-b1430c2c358a/dcop_a_187661_sf0001_c.jpg)
Figure S2 Scatter plots of IgG autoantibodies with pair-wise comparisons of the two measurements. Scatter plots of (A) anti-aggrecan IgG; (B) anti-amyloid IgG; (C) anti-CENP-B IgG; (D) anti-collagen I IgG; (E) anti-collagen II IgG; (F) anti-collagen IV IgG; (G) anti-cytochrome C IgG; (H) anti-cytokeratin 18 IgG; (I) anti-elastin IgG; (J) anti-HSP47 IgG; (K) anti-HSP70 IgG; (L) anti-SS-B IgG; and (M) anti-vimentin IgG.
Abbreviations: CENP-B, centromere protein B; HSP47, heat shock protein 47; HSP70, heat shock protein 70; SS-B, La/Sjögren syndrome type B antigen.
![Figure S2 Scatter plots of IgG autoantibodies with pair-wise comparisons of the two measurements. Scatter plots of (A) anti-aggrecan IgG; (B) anti-amyloid IgG; (C) anti-CENP-B IgG; (D) anti-collagen I IgG; (E) anti-collagen II IgG; (F) anti-collagen IV IgG; (G) anti-cytochrome C IgG; (H) anti-cytokeratin 18 IgG; (I) anti-elastin IgG; (J) anti-HSP47 IgG; (K) anti-HSP70 IgG; (L) anti-SS-B IgG; and (M) anti-vimentin IgG.Abbreviations: CENP-B, centromere protein B; HSP47, heat shock protein 47; HSP70, heat shock protein 70; SS-B, La/Sjögren syndrome type B antigen.](/cms/asset/9e688e5a-58ab-40c9-95e5-c9db6b758ec5/dcop_a_187661_sf0002_c.jpg)
Figure S3 Scatter plots of IgM autoantibodies with pair-wise comparisons of the two measurements. Scatter plots of (A) anti-aggrecan IgM; (B) anti-amyloid IgM; (C) anti-CENP-B IgM; (D) anti-collagen I IgM; (E) anti-collagen II IgM; (F) anti-collagen IV IgM; (G) anti-cytochrome C IgM; (H) anti-cytokeratin 18 IgM; (I) anti-elastin IgM; (J) anti-HSP47 IgM; (K) anti-HSP70 IgM; (L) anti-SS-B IgM; (M) anti-vimentin IgM.
Abbreviations: CENP-B, centromere protein B; HSP47, heat shock protein 47; HSP70, heat shock protein 70; SS-B, La/Sjögren syndrome type B antigen.
![Figure S3 Scatter plots of IgM autoantibodies with pair-wise comparisons of the two measurements. Scatter plots of (A) anti-aggrecan IgM; (B) anti-amyloid IgM; (C) anti-CENP-B IgM; (D) anti-collagen I IgM; (E) anti-collagen II IgM; (F) anti-collagen IV IgM; (G) anti-cytochrome C IgM; (H) anti-cytokeratin 18 IgM; (I) anti-elastin IgM; (J) anti-HSP47 IgM; (K) anti-HSP70 IgM; (L) anti-SS-B IgM; (M) anti-vimentin IgM.Abbreviations: CENP-B, centromere protein B; HSP47, heat shock protein 47; HSP70, heat shock protein 70; SS-B, La/Sjögren syndrome type B antigen.](/cms/asset/b84d904f-575c-4306-96d5-56c567e6909d/dcop_a_187661_sf0003_c.jpg)
Figure S4 Scatter plots of sputum cell counts with pair-wise comparisons of the two measurements. Scatter plots of (A) sputum neutrophils; (B) sputum macrophages; (C) sputum eosinophils; and (D) scatter plots of sputum lymphocytes.
![Figure S4 Scatter plots of sputum cell counts with pair-wise comparisons of the two measurements. Scatter plots of (A) sputum neutrophils; (B) sputum macrophages; (C) sputum eosinophils; and (D) scatter plots of sputum lymphocytes.](/cms/asset/1134b4f6-d2dd-4ce7-b208-37efa0021f52/dcop_a_187661_sf0004_c.jpg)
Table S1 All measurement results
Table S2 Comparison of measurements between groups